The Horseracing Integrity and Safety Authority (HISA) was back in the news earlier this month when the HISA Board of Directors ruled that the there would be no change to the status quo when it came to the rules regarding Lasix. To discuss the Lasix decision, another drop in the number of fatalities, the controversies surrounding why so many pre-race vet reviews are leading to scratches, the HERF initiative and more, HISA CEO Lisa Lazarus dropped by this week's TDN Writers' Room.
